Modeling 1-year Relapse-free Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients with Clinical T2–4N0M0 Urothelial Bladder Carcinoma: Endpoints for Phase 2 Trials-Reference-Cited by-同舟云学术

Modeling 1-year Relapse-free Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients with Clinical T2–4N0M0 Urothelial Bladder Carcinoma: Endpoints for Phase 2 Trials

Published:2019-05 Issue:3 Volume:2 Page:248-256
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Bandini Marco^ORCID,Briganti Alberto,Plimack Elizabeth R.^ORCID,Niegisch Günter^ORCID,Yu Evan Y.,Bamias Aristotelis^ORCID,Agarwal Neeraj^ORCID,Sridhar Srikala S.,Sternberg Cora N.,Vaishampayan Ulka,Théodore Christine,Rosenberg Jonathan E.,Bellmunt Joaquim,Galsky Matthew D.,Montorsi Francesco,Necchi Andrea^ORCID

Publisher

Elsevier BV

Subject

Urology,Radiology Nuclear Medicine and imaging,Oncology,Surgery

Reference26 articles.

1. Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer;Witjes;Eur Urol,2017

2. International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial;J Clin Oncol,2011

3. Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer;Zargar;Eur Urol,2015

4. Systemic, perioperative management of muscle-invasive bladder cancer and future horizons;Funt;Nat Rev Clin Oncol,2017

5. Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial;Sternberg;Lancet Oncol,2015

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel nomogram based on body composition and nutritional indicators to predict the prognosis of patients with muscle‐invasive bladder cancer undergoing radical cystectomy;Cancer Medicine;2023-11-16

2. Update of the Diagnostic and Therapeutic Role of the Pelvic Lymph Node Dissection Boundaries During Radical Cystectomy in Muscle Invasive Bladder Cancer;The Korean Journal of Urological Oncology;2022-05-31

3. The Gut and Urinary Microbiota: A Rising Biomarker in Genitourinary Malignancies;Neoadjuvant Immunotherapy Treatment of Localized Genitourinary Cancers;2022

4. Adjuvant Radiotherapy After Radical Cystectomy for Patients with High-risk Muscle-invasive Bladder Cancer: Results of a Multicentric Phase II Trial;European Urology Focus;2021-12

5. The effect of neoadjuvant chemotherapy among patients undergoing radical cystectomy for variant histology bladder cancer: A systematic review;Arab Journal of Urology;2021-11-07